A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy

INTRODUCTION: Local recurrence (LR) is clinical challenge in the treatment of esophageal squamous cell carcinoma (ESCC). The current study aimed to determine the optimal re-irradiation dose for local recurrent esophageal squamous cell carcinoma (LRESCC) following radical (chemo) radiotherapy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xun, Hu, Xingsheng, Chen, Junru, He, Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186078/
https://www.ncbi.nlm.nih.gov/pubmed/34103059
http://dx.doi.org/10.1186/s13014-021-01828-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186078/
https://www.ncbi.nlm.nih.gov/pubmed/34103059
http://dx.doi.org/10.1186/s13014-021-01828-z

Ejemplares similares